Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Change in Account Payables (2016 - 2025)

Arrowhead Pharmaceuticals' Change in Account Payables history spans 16 years, with the latest figure at $15.3 million for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 397.33% year-over-year to $15.3 million; the TTM value through Dec 2025 reached $18.5 million, up 84.87%, while the annual FY2025 figure was $6.3 million, 213.55% up from the prior year.
  • Change in Account Payables reached $15.3 million in Q4 2025 per ARWR's latest filing, up from -$15.4 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $28.0 million in Q3 2023 to a low of -$15.4 million in Q3 2025.
  • Average Change in Account Payables over 5 years is $2.4 million, with a median of -$54000.0 recorded in 2021.
  • Peak YoY movement for Change in Account Payables: skyrocketed 1284.53% in 2022, then crashed 501.5% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at -$5.4 million in 2021, then skyrocketed by 61.55% to -$2.1 million in 2022, then plummeted by 501.5% to -$12.5 million in 2023, then skyrocketed by 124.62% to $3.1 million in 2024, then skyrocketed by 397.33% to $15.3 million in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Change in Account Payables are $15.3 million (Q4 2025), -$15.4 million (Q3 2025), and $23.4 million (Q2 2025).